Latest News about Exclusives
Recent news which mentions Exclusives
EXCLUSIVE: Alzamend Neuro Initiates First Phase 2 Trial Of Lead Program In Healthy Human Participants
May 13, 2025
From Benzinga
From Benzinga
EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In Treatment-Resistant Lung Cancer Patients
May 12, 2025
From Benzinga
EXCLUSIVE: DeFi Development Makes Record Solana Purchase, Surpasses $100 Million In Treasury Holdings
May 12, 2025
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
May 10, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
EXCLUSIVE: Aduro's Deal With Cleanfarms Targets Farm Plastic Recycling Revolution And Scalable Sustainability
May 08, 2025
From Benzinga
They Turned Fruit Bouquets Into A $500 Million-A-Year Business—Now They're Selling THC. Here's Why
May 07, 2025
From Benzinga
EXCLUSIVE: Trump's Approval Rating Drops In Reader Survey After 100 Days, Could Stock Market Be To Blame?
May 07, 2025
Tickers
SPY
From Benzinga
EXCLUSIVE: Alzamend Neuro Partners with QMENTA To Advance AI-Powered Imaging For Is Phase 2 Trial Of Lead Program
May 07, 2025
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.